Tai Chi Training for Persons With Multiple Sclerosis.

Brief summary (registry, in English)

Tai Chi combines strength and neuromuscular training with diaphragmatic breathing, attention, imagery and relaxation. After an initial learning period, participants can practise independently, potentially supporting self-efficacy and sustained self-management. Studies in chronic disease report benefits for physical function and psychological wellbeing. The investigators will evaluate a 12-week Tai Chi rehabilitation programme in a clincial trial. The Multiple Sclerosis Impact Scale (MSIS-29) is the primary clinical outcome, reflecting the physical and psychological consequences of multiple sclerosis (MS). Assessments take place before training and at 12 weeks (the primary endpoint). The study will address whether Tai Chi improves physical and mental health; reduces fatigue, anxiety, depression and pain; improves lower-limb strength, gait and balance; and improves quality of life and self-efficacy.

What you commit to

• Study type: Interventional
• Planned participants: 35
• From 1 Mar 2025 to the primary completion date, 31 Dec 2027
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.